Share Buybacks
Regeneron Pharmaceuticals Share Buybacks increased by 18.3% to $794.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 23.7%, from $1.04B to $794.30M. Over 4 years (FY 2021 to FY 2025), Share Buybacks shows an upward trend with a 20.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Large repurchases signal that management believes the stock is undervalued or that they have excess cash with no better internal investment opportunities.
Detailed definition
The cash spent by a company to buy back its own shares from the open market. This reduces the total number of shares out...
Peer comparison
Highly profitable tech giants often prioritize repurchases over dividends due to tax efficiencies and the impact on EPS.
share_repurchasesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $305.20M | $166.40M | $866.90M | $358.10M | $359.00M | $934.60M | $431.10M | $710.70M | $688.80M | $546.50M | $289.00M | $291.30M | $603.90M | $735.10M | $973.00M | $1.04B | $1.06B | $664.00M | $671.70M | $794.30M |
| QoQ Change | — | -45.5% | +421.0% | -58.7% | +0.3% | +160.3% | -53.9% | +64.9% | -3.1% | -20.7% | -47.1% | +0.8% | +107.3% | +21.7% | +32.4% | +7.0% | +1.9% | -37.4% | +1.2% | +18.3% |
| YoY Change | — | — | — | — | +17.6% | +461.7% | -50.3% | +98.5% | +91.9% | -41.5% | -33.0% | -59.0% | -12.3% | +34.5% | +236.7% | +257.5% | +75.8% | -9.7% | -31.0% | -23.7% |
Share Buybacks at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's share buybacks?
- Regeneron Pharmaceuticals (REGN) reported share buybacks of $794.30M in Q1 2026.
- How has Regeneron Pharmaceuticals's share buybacks changed year-over-year?
- Regeneron Pharmaceuticals's share buybacks decreased by 23.7% year-over-year, from $1.04B to $794.30M.
- What is the long-term trend for Regeneron Pharmaceuticals's share buybacks?
- Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's share buybacks has grown at a 20.2% compound annual growth rate (CAGR), from $1.65B to $3.44B.
- What does share buybacks mean?
- The money a company spends to buy back its own stock.